Changzhou No.2 People's Hospital

Changzhou, Jiangsu 213164

0 studies enrolling now · 9 studies all time

What they study most

Cachexia, Cardiovascular Risk, Chronic Kidney Disease, Colorectal Cancer, Crohn's Disease, Diabetes, Fatigue, Heart Failure, Inflammation, Loss of Appetite, Non-alcoholic Steatohepatitis, Non-small Cell Lung Cancer

Studies at this site

• Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) — Running, not enrolling
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
• Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15 — Completed
• A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Running, not enrolling
• ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 — Completed
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed
• A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time — Completed
• Levels of Inflammation in People With Cardiovascular Disease (POSEIDON) — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed